文献速递类风湿关节炎

类风湿关节炎5年死亡率改善与一般人群比较:死亡率差距缩小

Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap.
PubMed 文献 · Ann Rheum Dis · 2016-12-28

该基于加拿大不列颠哥伦比亚省行政健康数据的 population-based 队列研究,纳入1996-2000年与2001-2006年两个发病队列的RA患者及1:1匹配的一般人群对照,随访5年。结果显示早期队列RA较对照全因死亡率显著升高( adjusted HR 1.40, 95%CI 1.30-1.51),而后期队列无显著差异( adjusted HR 0.97, 95%CI 0.89-1.05),提示RA相对于一般人群的5年死亡率差距随时间改善。

要点

  • 1996-2000年发病RA队列5年全因死亡率显著高于对照( adjusted HR 1.40, 95%CI 1.30-1.51)。
  • 2001-2006年发病RA队列5年全因死亡率与对照无显著差异( adjusted HR 0.97, 95%CI 0.89-1.05)。
  • 全因、心血管疾病和癌症死亡率的RA与对照差异在两个发病队列间交互作用 p<0.01。

核心结论

  • 在 population-based 发病RA队列中,RA相对于一般人群的5年死亡率随时间改善,2000年后发病者未见5年内死亡率增加。

主要发现

  • 共纳入24 914例RA病例和对照,RA病例中发生2 747例死亡,对照中发生2 332例死亡。
  • RA与对照的全因、心血管疾病和癌症死亡率差异在两个发病队列间交互作用 p<0.01。
  • 较早队列RA较对照全因死亡率 adjusted HR 为1.40(95%CI 1.30-1.51),较晚队列为0.97(95%CI 0.89-1.05)。

临床怎么用

  • 对于2000年后发病的RA患者,5年内全因死亡率与一般人群无显著差异,提示治疗改善可能缩小了死亡率差距。
  • 对2000年前发病的RA患者,仍需关注其5年内全因死亡风险较一般人群升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Excess mortality in rheumatoid arthritis (RA) is expected to have improved over time, due to improved treatment. Our objective was to evaluate secular 5-year mortality trends in RA relative to general population controls in incident RA cohorts diagnosed in 1996-2000 vs 2001-2006. METHODS: We conducted a population-based cohort study, using administrative health data, of all incident RA cases in British Columbia who first met RA criteria between January 1996 and December 2006, with general population controls matched 1:1 on gender, birth and index years. Cohorts were divided into earlier (RA onset 1996-2000) and later (2001-2006) cohorts. Physician visits and vital statistics data were obtained until December 2010. Follow-up was censored at 5 years to ensure equal follow-up in both cohorts. Mortality rates, mortality rate ratios and HRs for mortality (RA vs controls) using proportional hazard models adjusting for age, were calculated. Differences in mortality in RA versus controls between earlier and later incident cohorts were tested via interaction between RA status (case/control) and cohort (earlier/later). RESULTS: 24 914 RA cases and controls experienced 2747 and 2332 deaths, respectively. Mortality risk in RA versus controls differed across incident cohorts for all-cause, cardiovascular diseases (CVD) and cancer mortality (interactions p<0.01). A significant increase in mortality in RA versus controls was observed in earlier, but not later, cohorts (all-cause mortality adjusted HR (95% CI): 1.40 (1.30 to 1.51) and 0.97 (0.89 to 1.05), respectively). CONCLUSIONS: In our population-based incident RA cohort, mortality compared with the general population improved over time. Increased mortality in the first 5 years was observed in people with RA onset before, but not after, 2000.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Lacaille D, Avina-Zubieta JA, Sayre EC, et al. Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap. Ann Rheum Dis. 2016. PMID: 28031164. doi:10.1136/annrheumdis-2016-209562

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。